Skip to content
About Us
About Synexa
Quality
Management
News
Environmental Sustainability
Services
Translational
Biomarkers
Bioanalysis
Technologies
Mass Spectrometry
Immunoassay
Olink Proteomics
Flow Cytometry
ELISpot
Radiopharmaceutical
Genomics
Tissue Imaging
Dose Formulation Analysis
Expertise
Autoimmune
Oncology
Vaccines
Biosimilars
Resources
Synexa Insights
Guides
Webinars
Events
Careers
Opportunities
Why Join Synexa
About Us
About Synexa
Quality
Management
News
Environmental Sustainability
Services
Translational
Biomarkers
Bioanalysis
Technologies
Mass Spectrometry
Immunoassay
Olink Proteomics
Flow Cytometry
ELISpot
Radiopharmaceutical
Genomics
Tissue Imaging
Dose Formulation Analysis
Expertise
Autoimmune
Oncology
Vaccines
Biosimilars
Resources
Synexa Insights
Guides
Webinars
Events
Careers
Opportunities
Why Join Synexa
Contact
Linkedin-in
Youtube
Blogs
Resources
Blogs
Latest Blogs
Search
EBF OS 2025: My Key Highlights
December 10, 2025
A unifying message across EBF 2025 was that bioanalytical science is transitioning from technical execution to decision support. For years, our industry has focused on…
Read More
Potential concussion biomarkers discovered in circulating blood after brain injury
July 16, 2020
Concussions are a commonly diagnosed injury in many sports, particularly at college or professional levels. While the diagnosis of a…
Read More
Complement C4 Genes and Sex-Biased Disease Susceptibility
July 16, 2020
There are many examples of diseases in which there is a sex bias, however, the underlying biology of this bias…
Read More
A unifying expression signature for SLE
July 16, 2020
Systemic Lupus Erythematosus (SLE) is an inflammatory autoimmune condition characterised by a wide variety of symptoms including skin rashes, oral…
Read More
← Previous
Page
1
…
Page
11
Page
12
Page
13
Next →
Search
Quick Links
Services
Contact us
Synexa Insights
Events
About us
Talk to our Biomarker Experts
